期刊文献+

尼古丁抑制6-羟基多巴胺损伤诱导的CD8^+T淋巴细胞浸润

Nicotine inhibit the recruitment of CD8 lymphocytes produced by 6-hydroxydopamine lesion in the striatum of SD rat
下载PDF
导出
摘要 目的:采用6-羟基多巴胺部分损伤大鼠帕金森病模型,探讨尼古丁保护多巴胺能神经元的机制。方法:动物分别接受尼古丁(0.2mg/kg或2.0mg/kg)或生理盐水腹膜腔内注射。注射7天后,尼古丁高、低剂量治疗组和模型对照组动物分别接受纹状体内6-OHDA20μg注射,制作部分损伤帕金森病模型。免疫组织化学及体视学方法定量分析黑质多巴胺能神经元和纹状体CD8+T淋巴细胞数量。结果:尼古丁低剂量治疗组和高剂量治疗组,6-OHDA注射侧的酪氨酸羟化酶免疫阳性细胞分别为相应对照侧的64.97±10.33%和67.24±12.67%;和模型对照组(25.27±11.79%)比较,差异有统计学意义(P<0.01)。此外,尼古丁也可明显减少纹状体CD8+T淋巴细胞浸润(P<0.05)。结论:尼古丁可能通过抑制CD8+T淋巴细胞浸润,保护多巴胺能神经元。 Objective: To explore the mechanism through which nicotine protects dopaminergic neurons against 6-OHDA toxicity in SD rat PD model. Methods: Rats received nicotine or saline treatment (two doses tested,0.2 mg/ kg and 2 mg/ kg, 5 injections i.p. per day at 2-h intervals). 8 days after the treatment, a single injection of 20μg 6-OHDA was administered into striatum. Nicotine or saline was administered daily until animals were sacrificed. The dopaminergic neurons and CD8-positive lymphocytes were analyzed quantitatively using immunohistochemistry and stereology. Results: The loss of dopaminergic neurons induced by 6-OHDA in the substantia nigra was significantly less severe in the nicotine treatment groups (at both 0.2 and 2 mg/kg groups) than in the saline treated group(P〈0.01). In addition, the number of CD8-positive lymphocytes reduced significantly in the nicotine treated animals as compared to saline control(P〈0.05). Conclusion: Our data suggest that nicotine may have a neuroprotective effect against 6-OHDA induced dopaminergic lesion by inhibiting the recruitment of CD8-positive lymphocytes.
出处 《脑与神经疾病杂志》 2007年第6期405-407,414,共4页 Journal of Brain and Nervous Diseases
基金 国家自然科学基金资助项目(30671950 30430280 30371574) 国家科技攻关计划基金资助项目(2004BA720A03)
关键词 尼古丁 帕金森病 6-OHDA CD8^+淋巴细胞 Nicotine Parkinson's disease 6-OHDA CD8-positive lymphocyte
  • 相关文献

参考文献7

  • 1Costa G, Abin-Carriquiry JA, Dajas F. Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra. Brain Res, 2001,888(2) :336-342
  • 2Meshul CK, Kamel D, Moore C, et al. Nicotine alters striatal glutamate function and decreases the apomorphine-induced contralateral rotations in 6-OHDA-lesioned rats. Exp Neurol, 2002,175(1) :257 -74
  • 3徐胜利,周明,刘平,张丽艳,徐艳玲,张愚,陈彪.6-羟多巴诱导大鼠黑质的持续胶质细胞反应[J].神经解剖学杂志,2005,21(2):133-138. 被引量:6
  • 4Kurkowska-Jastrzebska I, Wronska A, Kohutnicka M, et al. MHC class Ⅱ positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson's disease. Acta Neurobiol Exp,1999,59(1) : 1-8
  • 5Roceri M, Molteni R, Fumagalli F, et al. Stimulatory role of dopamine on fibroblast growth factor-2 expression in rat striatum. J Neurochem, 2001, 76:990-997
  • 6Quik M. Smoking, nicotine and Parkinson's disease. Trends Neurosci, 2004, 27.- 561-568
  • 7Shytle RD, Mori T, Townsend K, et al. Cholinergic modulation of microglial activation by α7 nicotinic receptors. J Neurochem, 2004, 89:337 -343

二级参考文献14

  • 1Vila M, Jackson-Lewis V, Guegan C et al. The role of glial cells in Parkinson's disease. Curr Opin Neurol, 2001; 14:483 - 489.
  • 2Przedborski S, Vila M. The 1-methy-4-phenyl-1, 2,3,6-tetrahydropridine mouse model: a toll to explore the pathogenesis of Parkinson's disease. Ann NY Acad Sci, 2003 ;991:189 -198.
  • 3Gao HM, Liu B, Zhang W et al. Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease. FASEB J, 2003; 17:1954 - 1956.
  • 4Sherer TB, Betarbet R, Kim JH et al. Selective microglial activation in the rat rotenone model of Parkinson's disease. Neurosci Lett, 2003 ;341:87 -90.
  • 5Rodrigues RW, Gomide VC, Chadi G. Astroglial and microglial reaction after a partial nigrostriatal degeneration induced by the striatal injection of different doses of 6-hydroxydopamine. Int J Neurosci, 2001 ;109:91 - 126.
  • 6Wu DC, Jackson-Lewis V, Vila M et al. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci,2002 ;22:1763 - 1771.
  • 7Kalla R, Liu ZQ, Xu SL et al. Microglia and the early phase of immune surveillance in the axtomized facial motor nucleus: impaired microglial activation and lymphocyte recruitment but not effect on neuronal survival or axonal regeneration in macrophage-colony stimulating factor-deficient mice. J Comp Neurol, 2001; 436: 182 -201.
  • 8Werner A, Kloss CUA, Walter J et al. Intercellular adhesion molecule-1 ( ICAM-1 ) in the regenerating mouse facial motor nucleus.J Neurocytol, 1998 ;27:219 - 232.
  • 9Teismann P, Tieu K, Cohen O et al. Pathogenic role of glial cells in Parkinson's disease. Mov Disord, 2003; 18:121 - 129.
  • 10Raivich G, Bohatschek M, Kloss CU et al. Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function. Brain Res Brain Res Rev, 1999 ;30:77 - 105.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部